A phase 2 trial of Endoscopic resection in Nasal cavity and paranasal sinus cancers, run by Memorial Sloan Kettering Cancer Center, completed.
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages is a phase 2 interventional study registered as NCT03274414 by Memorial Sloan Kettering Cancer Center, with 3 participants recorded, started 2017-09-01 and reaching its primary completion in 2023-01-13. Interventions recorded: Cisplatin, Adjuvant Proton Radiotherapy, Endoscopic Resection, cisplatin and etoposide. Conditions recorded: Paranasal Sinus Cancer, Nasal Cavity Tumor, Nasal Cavity Adenocarcinoma.
Linked to the technology Endoscopic resection because the registry names it ("endoscopic resection") among its interventions and Nasal cavity and paranasal sinus cancers among its conditions. Registry record only: no result has been read by an editor.
Shares Endoscopic resection (EMR / ESD) and the tag pipeline.
Shares Endoscopic resection (EMR / ESD) and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.